The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis
Abstract
Background Male breast cancer is rare and understudied compared with female breast cancer. A current comparison with female breast cancer could assist in bridging this gap. Although conflicting data have been reported on male and female survival outcomes, data from 1973 through 2005 in the Surveillance, Epidemiology, and End Results (SEER) program have demonstrated that the improvement in breast cancer survival in men has fallen behind that of women. As treatment for breast cancer has improved significantly, an updated analysis using a contemporary population is necessary. Materials and Methods An analysis of SEER data from patients with a diagnosis of primary breast cancer from 2005 to 2010 were included. A Cox regression model was used to examine the association between sex and breast cancer mortality after controlling for prognostic factors, including age, race, marital status, disease stage, estrogen and progesterone receptor status, lymph node involvement, tumor grade, surgery, and geography. Subgroup analyses were performed by race and stage. Results We included a total of 289,673 breast cancer cases (2054 men) with a diagnosis from 2005 to 2010. The 5‐year survival rate for male patients was lower than that for female patients (82.8% vs. 88.5%). After controlling for other factors, the risk of death in men was 43% greater than that in women during the follow‐up period (hazard ratio, 1.43; 95% confidence interval, 1.26‐1.61). Similar results were noted in the race and stage subgroup analyses. Conclusion In recent years, male breast cancer patients have had worse survival outcomes compared with those of female patients. Micro‐Abstract Whether the survival prognosis of male breast cancer differs from that of female breast cancer remains unclear. The present study used the recently updated Surveillance, Epidemiology, and End Results data to compare the breast cancer survival outcomes between the sexes at a population level and found a significant disadvantage for the male patients. This finding suggests a need to develop male‐specific treatment strategies in breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Cited by
Epidemiology of male breast cancer
Konduri, S., Singh, M., Bobustuc, G., Rovin, R., & Kassam, A. (2020) · The Breast · doi:10.1016/j.breast.2020.08.010 · Cited by 411
Metadata
- Authors
- Liu, N., Johnson, K. J., & Ma, C. X.
- Venue
- Clinical Breast Cancer
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 18
- Issue
- 5
- Pages
- e997-e1002
- ISSN
- 1526-8209 (ISSN-L)
- OpenAlex
- W2811313942
- Cited by
- 161
- References
- 2
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis. https://app.cochat.ai/papers/10.1016/j.clbc.2018.06.013
- The paper
- Liu, N., Johnson, K. J., & Ma, C. X. (2018). Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2018.06.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.